Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene

G. H.G. Sinnecker*, O. Hiort, E. M. Nitsche, P. M. Holterhus, K. Kruse, I. Akkurt, N. Albers, W. Blunck, J. Brämswig, H. G. Dörr, H. Guhde, W. Hecker, P. Heidemann, V. Hesse, K. Hinkel, W. Hoepffner, M. Holder, M. Klasen, G. Krüger, F. A. LeidenbergerM. Mix, M. Morlot, R. Mühlenberg, L. Pelz, H. Reich, D. Schnabel, R. Sinnecker, R. P. Willig

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

In the genetic male, mutations of the androgen receptor (AR) gene cause phenotypes ranging from female to subfertile male. Binding assays on genital skin fibroblasts and DNA analysis alone provide incomplete information about receptor function. We used the sex hormone-binding globulin (SHBG) response to stanozolol as a measure of AR function and correlated the results with phenotypes which were classified according to the degree of defective masculinization. Of the 34 patients investigated, 9 had complete, and 14 had partial androgen insensitivity syndrome (AIS) with predominantly female, ambiguous, or predominantly male phenotype. Eleven subjects served as controls. Mutations were characterized using polymerase chain reaction-single strand conformation polymorphism analysis and direct DNA sequencing. DNA analysis revealed two major deletions, two minor defects leading to premature stop codons in exon 1, and 19 point mutations in the DNA- and hormone-binding domains of the AR gene. After stanozolol, SHBG remained unchanged in patients with complete AIS (102.0 ± 3.8 [SE]%; range 92.4%-129% of the initial value). The SHBG decrease was diminished in partial AIS with predominantly female (83.8% ± 1.7%; range 81.3%-87.0%), ambiguous (80.4% ± 4.4%, range 68.4%-89.1%), and predominantly male (mean 65.9% ± 4.9%, range 48.6%-80.8%) phenotypes, and normal in controls (51.4% ± 2.1%, range 35.6%-62.1%). Differences between controls and each AIS group were statistically significant (P < 0.05 - < 0.0001). A close correlation was found between the degree of undermasculinization (AIS phenotype) and the SHBG response. Conclusions. The SHBG test provides functional information about the severity of the receptor defect in vivo and hence adds to the structural information provided by DNA analysis. It detects receptor defects due to mutations within the entire gene, including the DNA-binding domain, and is a rapid, simple, and cost effective procedure. It may provide useful information for the diagnosis and management of affected children.

OriginalspracheEnglisch
ZeitschriftEuropean Journal of Pediatrics
Jahrgang156
Ausgabenummer1
Seiten (von - bis)7-14
Seitenumfang8
ISSN0340-6199
DOIs
PublikationsstatusVeröffentlicht - 1997

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality
  3. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren